Geriatric companion animals (dogs over 7, cats over 10) represent the fastest-growing demographic in veterinary practice, driving disproportionate spending on chronic disease management, mobility, cognitive support, and end-of-life care. Mobility issues — primarily osteoarthritis — are the most common geriatric concern and are addressed by Zoetis's Librela monoclonal antibody and the Galliprant/Rimadyl/Onsior NSAID portfolio. Cognitive dysfunction syndrome (canine dementia) affects 20%+ of dogs over 11 and is treated with selegiline and S-adenosyl-methionine supplementation. Hospice and palliative care services are emerging as a distinct veterinary specialty.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Geriatric Pet Care Market Size, Growth and Forecast 2025-2030
• Demographic Trends — Aging Pet Population by Region
• Mobility and Osteoarthritis Therapeutics — Librela, NSAIDs, Joint Supplements
• Cognitive Dysfunction Syndrome — Diagnosis and Treatment
• Chronic Kidney Disease in Geriatric Cats
• Cardiac Disease Management in Senior Dogs
• Cancer Screening and Treatment in Geriatric Pets
• Sensory Decline — Vision, Hearing, Cognitive Support
• Hospice and Palliative Veterinary Care Services
• Quality-of-Life Assessment and End-of-Life Decision Support
Table of Contents
1. Executive Summary
2. Market Overview
3. Geriatric Pet Care Market Size, Growth and Forecast 2025-2030
4. Demographic Trends
5. Mobility and Osteoarthritis Therapeutics
6. Cognitive Dysfunction Syndrome
7. Chronic Kidney Disease
8. Cardiac Disease
9. Cancer in Geriatric Pets
10. Sensory Decline
11. Hospice and Palliative Care
12. Quality-of-Life Assessment
13. Market Challenges and Risks
14. Competitive Landscape
15. Strategic Conclusions and Recommendations
16. Appendix
List of Tables
Table 1. Geriatric Pet Care Market Size and Forecast 2025-2030
Table 2. Aging Pet Population Demographics by Region
Table 3. Mobility Therapeutic Sales — Librela, NSAIDs, Supplements
Table 4. Cognitive Dysfunction Syndrome Treatment Sales
Table 5. CKD Management Therapeutics in Cats
Table 6. Cardiac Disease Therapeutic Sales in Senior Dogs
Table 7. Cancer Screening Volume in Geriatric Pets
Table 8. Hospice Service Provider Market by Region
Table 9. Quality-of-Life Assessment Tool Adoption
Table 10. Competitive Positioning by Geriatric Disease State
Companies Profiled
Boehringer Ingelheim Animal Health
Ceva Santé Animale
Dechra Pharmaceuticals
Elanco Animal Health
IDEXX Laboratories
Merck Animal Health
Vetoquinol
Virbac
Zoetis
